0001104659-16-145695.txt : 20160920 0001104659-16-145695.hdr.sgml : 20160920 20160920160332 ACCESSION NUMBER: 0001104659-16-145695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160401 FILED AS OF DATE: 20160920 DATE AS OF CHANGE: 20160920 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001338042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202960116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 500-7867 MAIL ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc DATE OF NAME CHANGE: 20050906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harshbarger Benjamin CENTRAL INDEX KEY: 0001653133 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34921 FILM NUMBER: 161893965 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 a4.xml 4 X0306 4 2016-04-01 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001653133 Harshbarger Benjamin C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142 0 1 0 0 General Counsel Common Stock 2016-04-01 4 M 0 867 A 867 D Common Stock 2016-04-01 4 F 0 273 3.55 D 594 D Common Stock 2016-09-17 4 M 0 1642 A 2236 D Common Stock 2016-09-17 4 F 0 532 1.78 D 1704 D Restricted Stock Units 2016-04-01 4 M 0 867 0.00 D Common Stock 867 1733 D Restricted Stock Units 2016-09-17 4 M 0 1642 0.00 D Common Stock 1642 3282 D Each restricted stock unit represents a contingent right to receive one share of common stock. 33.34% of the grant vested on April 1, 2016. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer, an additional 33.33% of the units will vest on each of April 1, 2017 and April 1, 2018. 33.34% of the grant vested on September 17, 2016. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer, an additional 33.33% of the units will vest on each of September 17, 2017 and September 17, 2018. /s/ Jennifer Fitzpatrick, attorney-in-fact 2016-09-20